United States Biotechnology & Medical Research

Monte Rosa Therapeutics Inc (GLUE)

Track

Track

Monte Rosa Therapeutics experienced significant selling activity over the past ninety days, with executives offloading shares worth over four hundred thousand dollars. These transactions occurred amid a twenty percent stock decline and a recent earnings report miss. Leadership, including the CEO and medical officers, executed multiple planned divestments, reflecting a consistent pattern of equity reduction.
Ticker: GLUE Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Monte Rosa Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Sale
Price
348.14
Quantity 55,117 -26.0%
Value US$1,087,663
1.9
MARKUS WARMUTH Officer Officer
Transaction date
Proposed sale
Price
154.25
Quantity 90,702
Value US$3,425,739
0.6
Champoux Jennifer Chief Operating Officer Officer
Transaction date
Planned sale
Price
347.80
Quantity 249 -39.3%
Value US$748,955
0.6
Champoux Jennifer Officer Officer
Transaction date
Proposed sale
Price
23.38
Quantity 4,351
Value US$101,730
0.6
Townson Sharon Chief Scientific Officer Officer
Transaction date
Planned sale
Price
24.13
Quantity 400 -0.6%
Value US$9,652
0.6
Townson Sharon Chief Scientific Officer Officer
Transaction date
Planned sale
Price
23.25
Quantity 5,600 -7.6%
Value US$130,197
2.3
Janku Filip Chief Medical Officer Officer
Transaction date
Planned sale
Price
24.50
Quantity 5,407 -8.2%
Value US$132,472
2.3
FILIP JANKU Officer Officer
Transaction date
Proposed sale
Price
23.90
Quantity 5,407
Value US$129,227
Manning Anthony M. Non-Executive Director
Transaction date
Sale
Price
23.11
Quantity 10,000 -100.0%
Value US$231,100
2.3
Janku Filip Chief Medical Officer Officer
Transaction date
Planned sale
Price
22.95
Quantity 6,000 -9.1%
Value US$137,700
2.3
FILIP JANKU Officer Officer
Transaction date
Proposed sale
Price
22.29
Quantity 6,000
Value US$133,740
ANTHONY M MANNING Director Non-Executive Director
Transaction date
Proposed sale
Price
23.11
Quantity 10,000
Value US$231,100
2.3
Janku Filip Chief Medical Officer Officer
Transaction date
Planned sale
Price
21.42
Quantity 30,000 -33.3%
Value US$642,681
2.3
FILIP JANKU Officer Officer
Transaction date
Proposed sale
Price
20.71
Quantity 30,000
Value US$621,300
2.3
Janku Filip Chief Medical Officer Officer
Transaction date
Planned sale
Price
20.22
Quantity 11,845 -16.5%
Value US$239,522
0.6
Townson Sharon Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 3,000 -4.2%
Value US$60,000
0.6
Champoux Jennifer Chief Operating Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 2,175 -3.4%
Value US$43,500
2.5
EDMUND DUNN Officer Officer
Transaction date
Proposed sale
Price
20.70
Quantity 16,665
Value US$344,986
2.3
FILIP JANKU Officer Officer
Transaction date
Proposed sale
Price
18.67
Quantity 11,845
Value US$221,146
0.6
Champoux Jennifer Officer Officer
Transaction date
Proposed sale
Price
18.41
Quantity 2,175
Value US$40,042
0.6
Champoux Jennifer Chief Operating Officer Officer
Transaction date
Planned sale
Price
19.00
Quantity 2,176 -3.4%
Value US$41,344
0.6
Townson Sharon Chief Scientific Officer Officer
Transaction date
Planned sale
Price
19.00
Quantity 3,000 -4.2%
Value US$57,000
0.6
Champoux Jennifer Officer Officer
Transaction date
Proposed sale
Price
17.93
Quantity 2,176
Value US$39,005
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Planned sale
Price
19.73
Quantity 468 -0.1%
Value US$9,232
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Planned sale
Price
19.73
Quantity 468 -0.1%
Value US$9,232
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Planned sale
Price
19.41
Quantity 4,998 -0.8%
Value US$97,021
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Planned sale
Price
19.41
Quantity 4,998 -0.8%
Value US$97,021
1.9
Warmuth Markus Officer Officer
Transaction date
Proposed sale
Price
19.44
Quantity 5,466
Value US$106,253
0.6
Townson Sharon Chief Scientific Officer Officer
Transaction date
Planned sale
Price
19.87
Quantity 6,000 -8.1%
Value US$119,220
0.6
SHARON TOWNSON Officer Officer
Transaction date
Proposed sale
Price
19.39
Quantity 24,000
Value US$465,360
0.6
Champoux Jennifer Chief Operating Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 2,175 -3.4%
Value US$43,500
0.6
Champoux Jennifer Officer Officer
Transaction date
Proposed sale
Price
19.33
Quantity 2,175
Value US$42,043
0.6
Champoux Jennifer Chief Operating Officer Officer
Transaction date
Planned sale
Price
19.00
Quantity 2,176 -3.4%
Value US$41,344
0.6
Champoux Jennifer Officer Officer
Transaction date
Proposed sale
Price
18.72
Quantity 2,176
Value US$40,735
Manning Anthony M. Non-Executive Director
Transaction date
Sale
Price
18.01
Quantity 10,000 -100.0%
Value US$180,100
ANTHONY M MANNING Director Non-Executive Director
Transaction date
Proposed sale
Price
18.01
Quantity 10,000
Value US$180,100
ANTHONY M MANNING Director Non-Executive Director
Transaction date
Proposed sale
Price
18.01
Quantity 10,000
Value US$180,100
1.9
Warmuth Markus Officer Officer
Transaction date
Proposed sale
Price
18.92
Quantity 5,467
Value US$103,447
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Planned sale
Price
18.92
Quantity 5,467 -0.9%
Value US$103,447
1.9
Warmuth Markus Officer Officer
Transaction date
Proposed sale
Price
18,922.01
Quantity 5,467
Value US$103,446,628
2.5
EDMUND DUNN Officer Officer
Transaction date
Proposed sale
Price
18.50
Quantity 18,683
Value US$345,636
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Sale
Price
17.64
Quantity 8,000 -1.3%
Value US$141,125
1.9
MARKUS WARMUTH Officer; Director Executive Director
Transaction date
Proposed sale
Price
17.64
Quantity 8,000
Value US$141,125
2.5
EDMUND DUNN Officer Officer
Transaction date
Proposed sale
Price
18.00
Quantity 16,687
Value US$300,366
1.4
Nickson Philip Chief Business & Legal Officer Officer
Transaction date
Sale
Price
17.69
Quantity 5,845 -9.6%
Value US$103,413
1.4
PHILIP NICKSON Officer Officer
Transaction date
Proposed sale
Price
17.69
Quantity 5,845
Value US$103,413
2.5
EDMUND DUNN Officer Officer
Transaction date
Proposed sale
Price
17.25
Quantity 26,117
Value US$450,623
2.5
Dunn Edmund Principal Accounting Officer Officer
Transaction date
Sale
Price
17.96
Quantity 139 -0.6%
Value US$2,496
2.5
Dunn Edmund Officer Officer
Transaction date
Proposed sale
Price
17.86
Quantity 139
Value US$2,482
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Planned sale
Price
17.92
Quantity 5,466 -0.9%
Value US$97,974
2.5
Dunn Edmund Principal Accounting Officer Officer
Transaction date
Sale
Price
17.50
Quantity 536 -2.3%
Value US$9,380
1.9
Warmuth Markus Officer Officer
Transaction date
Proposed sale
Price
17.92
Quantity 5,466
Value US$97,974
2.5
Edmund Dunn Officer Officer
Transaction date
Proposed sale
Price
17.50
Quantity 536
Value US$9,380
2.5
Dunn Edmund Principal Accounting Officer Officer
Transaction date
Sale
Price
18.10
Quantity 25,164 -52.6%
Value US$455,506
2.5
Edmund Dunn Officer Officer
Transaction date
Proposed sale
Price
18.10
Quantity 25,164
Value US$455,506
2.3
Janku Filip Chief Medical Officer Officer
Transaction date
Sale
Price
19.50
Quantity 9,189 -12.2%
Value US$179,161
2.3
FILIP JANKU Officer Officer
Transaction date
Proposed sale
Price
19.50
Quantity 9,189
Value US$179,161
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Planned sale
Price
24.57
Quantity 309 -0.0%
Value US$7,593
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Planned sale
Price
23.88
Quantity 1,450 -0.2%
Value US$34,620
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Planned sale
Price
23.24
Quantity 3,707 -0.6%
Value US$86,159
1.9
Warmuth Markus Officer Officer
Transaction date
Proposed sale
Price
23.49
Quantity 5,466
Value US$128,372
1.9
Warmuth Markus Officer Officer
Transaction date
Proposed sale
Price
23.49
Quantity 5,466
Value US$128,372
1.9
Warmuth Markus Officer; Director Executive Director
Transaction date
Proposed sale
Price
15.17
Quantity 10,135
Value US$153,759
2.5
Dunn Edmund Principal Accounting Officer Officer
Transaction date
Sale
Price
15.17
Quantity 1,039 -4.4%
Value US$15,762
2.3
Janku Filip Chief Medical Officer Officer
Transaction date
Sale
Price
15.17
Quantity 3,155 -4.0%
Value US$47,861
0.6
Champoux Jennifer Chief Operating Officer Officer
Transaction date
Sale
Price
15.17
Quantity 2,629 -4.0%
Value US$39,882
1.9
Warmuth Markus President & CEO Executive Director
Transaction date
Sale
Price
15.17
Quantity 10,135 -1.6%
Value US$153,748
1.4
Nickson Philip Chief Business & Legal Officer Officer
Transaction date
Sale
Price
15.17
Quantity 3,155 -4.9%
Value US$47,861
0.6
Townson Sharon Chief Scientific Officer Officer
Transaction date
Sale
Price
15.17
Quantity 3,155 -4.4%
Value US$47,861
2.5
Dunn Edmund Principal Accounting Officer Officer
Transaction date
Sale
Price
4.45
Quantity 2,062 -8.0%
Value US$9,174
0.8
Leo Chandra P. Non-Executive Director
Transaction date
Purchase
Price
5.84
Quantity 10,000 +inf%
Value US$58,383
Wallace Owen B. Officer Officer
Transaction date
Proposed sale
Price
12.00
Quantity 20,000
Value US$240,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-17 2026-07-16 S Sale
1.9
Warmuth Markus

President & CEO

Executive Director
55,117 -26.0%
348.14
US$1,087,663 		55,117 -26.0% 348.14 US$1,087,663
2026-07-16 2026-07-16 PrS Proposed sale
1.9
MARKUS WARMUTH

Officer

Officer
90,702
154.25
US$3,425,739 		90,702 154.25 US$3,425,739
2026-07-16 2026-07-15 PlS Planned sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
249 -39.3%
347.80
US$748,955 		249 -39.3% 347.80 US$748,955
2026-07-15 2026-07-15 PrS Proposed sale
0.6
Champoux Jennifer

Officer

Officer
4,351
23.38
US$101,730 		4,351 23.38 US$101,730
2026-07-07 2026-07-06 PlS Planned sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
400 -0.6%
24.13
US$9,652 		400 -0.6% 24.13 US$9,652
2026-07-07 2026-07-06 PlS Planned sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
5,600 -7.6%
23.25
US$130,197 		5,600 -7.6% 23.25 US$130,197
2026-07-01 2026-06-30 PlS Planned sale
2.3
Janku Filip

Chief Medical Officer

Officer
5,407 -8.2%
24.50
US$132,472 		5,407 -8.2% 24.50 US$132,472
2026-06-30 2026-06-30 PrS Proposed sale
2.3
FILIP JANKU

Officer

Officer
5,407
23.90
US$129,227 		5,407 23.90 US$129,227
2026-06-30 2026-06-29 S Sale
Manning Anthony M.
Non-Executive Director
10,000 -100.0%
23.11
US$231,100 		10,000 -100.0% 23.11 US$231,100
2026-06-30 2026-06-29 PlS Planned sale
2.3
Janku Filip

Chief Medical Officer

Officer
6,000 -9.1%
22.95
US$137,700 		6,000 -9.1% 22.95 US$137,700
2026-06-29 2026-06-29 PrS Proposed sale
2.3
FILIP JANKU

Officer

Officer
6,000
22.29
US$133,740 		6,000 22.29 US$133,740
2026-06-29 2026-06-29 PrS Proposed sale
ANTHONY M MANNING

Director

Non-Executive Director
10,000
23.11
US$231,100 		10,000 23.11 US$231,100
2026-06-25 2026-06-24 PlS Planned sale
2.3
Janku Filip

Chief Medical Officer

Officer
30,000 -33.3%
21.42
US$642,681 		30,000 -33.3% 21.42 US$642,681
2026-06-24 2026-06-24 PrS Proposed sale
2.3
FILIP JANKU

Officer

Officer
30,000
20.71
US$621,300 		30,000 20.71 US$621,300
2026-06-25 2026-06-23 PlS Planned sale
2.3
Janku Filip

Chief Medical Officer

Officer
11,845 -16.5%
20.22
US$239,522 		11,845 -16.5% 20.22 US$239,522
2026-06-25 2026-06-23 PlS Planned sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
3,000 -4.2%
20.00
US$60,000 		3,000 -4.2% 20.00 US$60,000
2026-06-25 2026-06-23 PlS Planned sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
2,175 -3.4%
20.00
US$43,500 		2,175 -3.4% 20.00 US$43,500
2026-06-23 2026-06-23 PrS Proposed sale
2.5
EDMUND DUNN

Officer

Officer
16,665
20.70
US$344,986 		16,665 20.70 US$344,986
2026-06-23 2026-06-23 PrS Proposed sale
2.3
FILIP JANKU

Officer

Officer
11,845
18.67
US$221,146 		11,845 18.67 US$221,146
2026-06-23 2026-06-23 PrS Proposed sale
0.6
Champoux Jennifer

Officer

Officer
2,175
18.41
US$40,042 		2,175 18.41 US$40,042
2026-06-18 2026-06-17 PlS Planned sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
2,176 -3.4%
19.00
US$41,344 		2,176 -3.4% 19.00 US$41,344
2026-06-18 2026-06-17 PlS Planned sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
3,000 -4.2%
19.00
US$57,000 		3,000 -4.2% 19.00 US$57,000
2026-06-17 2026-06-17 PrS Proposed sale
0.6
Champoux Jennifer

Officer

Officer
2,176
17.93
US$39,005 		2,176 17.93 US$39,005
2026-06-02 2026-06-01 PlS Planned sale
1.9
Warmuth Markus

President & CEO

Executive Director
468 -0.1%
19.73
US$9,232 		468 -0.1% 19.73 US$9,232
2026-06-02 2026-06-01 PlS Planned sale
1.9
Warmuth Markus

President & CEO

Executive Director
468 -0.1%
19.73
US$9,232 		468 -0.1% 19.73 US$9,232
2026-06-02 2026-06-01 PlS Planned sale
1.9
Warmuth Markus

President & CEO

Executive Director
4,998 -0.8%
19.41
US$97,021 		4,998 -0.8% 19.41 US$97,021
2026-06-02 2026-06-01 PlS Planned sale
1.9
Warmuth Markus

President & CEO

Executive Director
4,998 -0.8%
19.41
US$97,021 		4,998 -0.8% 19.41 US$97,021
2026-06-01 2026-06-01 PrS Proposed sale
1.9
Warmuth Markus

Officer

Officer
5,466
19.44
US$106,253 		5,466 19.44 US$106,253
2026-06-01 2026-05-29 PlS Planned sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
6,000 -8.1%
19.87
US$119,220 		6,000 -8.1% 19.87 US$119,220
2026-05-29 2026-05-29 PrS Proposed sale
0.6
SHARON TOWNSON

Officer

Officer
24,000
19.39
US$465,360 		24,000 19.39 US$465,360
2026-05-28 2026-05-27 PlS Planned sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
2,175 -3.4%
20.00
US$43,500 		2,175 -3.4% 20.00 US$43,500
2026-05-27 2026-05-27 PrS Proposed sale
0.6
Champoux Jennifer

Officer

Officer
2,175
19.33
US$42,043 		2,175 19.33 US$42,043
2026-05-26 2026-05-22 PlS Planned sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
2,176 -3.4%
19.00
US$41,344 		2,176 -3.4% 19.00 US$41,344
2026-05-22 2026-05-22 PrS Proposed sale
0.6
Champoux Jennifer

Officer

Officer
2,176
18.72
US$40,735 		2,176 18.72 US$40,735
2026-05-22 2026-05-21 S Sale
Manning Anthony M.
Non-Executive Director
10,000 -100.0%
18.01
US$180,100 		10,000 -100.0% 18.01 US$180,100
2026-05-21 2026-05-21 PrS Proposed sale
ANTHONY M MANNING

Director

Non-Executive Director
10,000
18.01
US$180,100 		10,000 18.01 US$180,100
2026-05-21 2026-05-21 PrS Proposed sale
ANTHONY M MANNING

Director

Non-Executive Director
10,000
18.01
US$180,100 		10,000 18.01 US$180,100
2026-06-02 2026-05-01 PrS Proposed sale
1.9
Warmuth Markus

Officer

Officer
5,467
18.92
US$103,447 		5,467 18.92 US$103,447
2026-05-05 2026-05-01 PlS Planned sale
1.9
Warmuth Markus

President & CEO

Executive Director
5,467 -0.9%
18.92
US$103,447 		5,467 -0.9% 18.92 US$103,447
2026-05-01 2026-05-01 PrS Proposed sale
1.9
Warmuth Markus

Officer

Officer
5,467
18,922.01
US$103,446,628 		5,467 18,922.01 US$103,446,628
2026-04-16 2026-04-16 PrS Proposed sale
2.5
EDMUND DUNN

Officer

Officer
18,683
18.50
US$345,636 		18,683 18.50 US$345,636
2026-04-15 2026-04-14 S Sale
1.9
Warmuth Markus

President & CEO

Executive Director
8,000 -1.3%
17.64
US$141,125 		8,000 -1.3% 17.64 US$141,125
2026-04-14 2026-04-14 PrS Proposed sale
1.9
MARKUS WARMUTH

Officer; Director

Executive Director
8,000
17.64
US$141,125 		8,000 17.64 US$141,125
2026-04-13 2026-04-13 PrS Proposed sale
2.5
EDMUND DUNN

Officer

Officer
16,687
18.00
US$300,366 		16,687 18.00 US$300,366
2026-04-10 2026-04-09 S Sale
1.4
Nickson Philip

Chief Business & Legal Officer

Officer
5,845 -9.6%
17.69
US$103,413 		5,845 -9.6% 17.69 US$103,413
2026-04-09 2026-04-09 PrS Proposed sale
1.4
PHILIP NICKSON

Officer

Officer
5,845
17.69
US$103,413 		5,845 17.69 US$103,413
2026-04-08 2026-04-08 PrS Proposed sale
2.5
EDMUND DUNN

Officer

Officer
26,117
17.25
US$450,623 		26,117 17.25 US$450,623
2026-03-05 2026-03-04 S Sale
2.5
Dunn Edmund

Principal Accounting Officer

Officer
139 -0.6%
17.96
US$2,496 		139 -0.6% 17.96 US$2,496
2026-03-04 2026-03-04 PrS Proposed sale
2.5
Dunn Edmund

Officer

Officer
139
17.86
US$2,482 		139 17.86 US$2,482
2026-03-04 2026-03-02 PlS Planned sale
1.9
Warmuth Markus

President & CEO

Executive Director
5,466 -0.9%
17.92
US$97,974 		5,466 -0.9% 17.92 US$97,974
2026-03-02 2026-03-02 S Sale
2.5
Dunn Edmund

Principal Accounting Officer

Officer
536 -2.3%
17.50
US$9,380 		536 -2.3% 17.50 US$9,380
2026-03-02 2026-03-02 PrS Proposed sale
1.9
Warmuth Markus

Officer

Officer
5,466
17.92
US$97,974 		5,466 17.92 US$97,974
2026-03-02 2026-03-02 PrS Proposed sale
2.5
Edmund Dunn

Officer

Officer
536
17.50
US$9,380 		536 17.50 US$9,380
2026-03-02 2026-02-27 S Sale
2.5
Dunn Edmund

Principal Accounting Officer

Officer
25,164 -52.6%
18.10
US$455,506 		25,164 -52.6% 18.10 US$455,506
2026-02-27 2026-02-27 PrS Proposed sale
2.5
Edmund Dunn

Officer

Officer
25,164
18.10
US$455,506 		25,164 18.10 US$455,506
2026-02-24 2026-02-23 S Sale
2.3
Janku Filip

Chief Medical Officer

Officer
9,189 -12.2%
19.50
US$179,161 		9,189 -12.2% 19.50 US$179,161
2026-02-23 2026-02-23 PrS Proposed sale
2.3
FILIP JANKU

Officer

Officer
9,189
19.50
US$179,161 		9,189 19.50 US$179,161
2026-01-09 2026-01-07 PlS Planned sale
1.9
Warmuth Markus

President & CEO

Executive Director
309 -0.0%
24.57
US$7,593 		309 -0.0% 24.57 US$7,593
2026-01-09 2026-01-07 PlS Planned sale
1.9
Warmuth Markus

President & CEO

Executive Director
1,450 -0.2%
23.88
US$34,620 		1,450 -0.2% 23.88 US$34,620
2026-01-09 2026-01-07 PlS Planned sale
1.9
Warmuth Markus

President & CEO

Executive Director
3,707 -0.6%
23.24
US$86,159 		3,707 -0.6% 23.24 US$86,159
2026-01-08 2026-01-07 PrS Proposed sale
1.9
Warmuth Markus

Officer

Officer
5,466
23.49
US$128,372 		5,466 23.49 US$128,372
2026-01-07 2026-01-07 PrS Proposed sale
1.9
Warmuth Markus

Officer

Officer
5,466
23.49
US$128,372 		5,466 23.49 US$128,372
2026-01-05 2026-01-05 PrS Proposed sale
1.9
Warmuth Markus

Officer; Director

Executive Director
10,135
15.17
US$153,759 		10,135 15.17 US$153,759
2026-01-05 2026-01-05 S Sale
2.5
Dunn Edmund

Principal Accounting Officer

Officer
1,039 -4.4%
15.17
US$15,762 		1,039 -4.4% 15.17 US$15,762
2026-01-05 2026-01-05 S Sale
2.3
Janku Filip

Chief Medical Officer

Officer
3,155 -4.0%
15.17
US$47,861 		3,155 -4.0% 15.17 US$47,861
2026-01-05 2026-01-05 S Sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
2,629 -4.0%
15.17
US$39,882 		2,629 -4.0% 15.17 US$39,882
2026-01-05 2026-01-05 S Sale
1.9
Warmuth Markus

President & CEO

Executive Director
10,135 -1.6%
15.17
US$153,748 		10,135 -1.6% 15.17 US$153,748
2026-01-05 2026-01-05 S Sale
1.4
Nickson Philip

Chief Business & Legal Officer

Officer
3,155 -4.9%
15.17
US$47,861 		3,155 -4.9% 15.17 US$47,861
2026-01-05 2026-01-05 S Sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
3,155 -4.4%
15.17
US$47,861 		3,155 -4.4% 15.17 US$47,861
2025-06-04 2025-06-03 S Sale
2.5
Dunn Edmund

Principal Accounting Officer

Officer
2,062 -8.0%
4.45
US$9,174 		2,062 -8.0% 4.45 US$9,174
2025-03-25 2025-03-24 B Purchase
0.8
Leo Chandra P.
Non-Executive Director
10,000 +inf%
5.84
US$58,383 		10,000 +inf% 5.84 US$58,383
2024-10-30 2024-10-29 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
15,600 -1.0%
9.41
US$146,793 		15,600 -1.0% 9.41 US$146,793
2024-10-30 2024-10-29 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
52,305 -3.2%
9.08
US$475,008 		52,305 -3.2% 9.08 US$475,008
2024-10-30 2024-10-28 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
89,990 -4.3%
9.66
US$869,240 		89,990 -4.3% 9.66 US$869,240
2024-10-28 2024-10-28 PrS Proposed sale
Wallace Owen B.

Officer

Officer
20,000
12.00
US$240,000 		20,000 12.00 US$240,000
Explore more

More insider trading research around Monte Rosa Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America